Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenyankangfu Tablets for Primary Glomerulonephritis
NCT02063100Phase 4Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Feb 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Shenyan Kangfu Tablet in primary glomerulonephritis, sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
Shenyan Kangfu Tablet
03
Conditions
primary glomerulonephritis
Beyond the preview
Go deeper on NCT02063100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02063100.